Dermatol. praxi. 2017;11(3):136-140 | DOI: 10.36290/der.2017.026

The combination of a papulopustulous rosacea with a perioral dermatitis at a 53 years old patient

MUDr. Zuzana Nevoralová, Ph.D.
Akné poradna, Dermatovenerologické oddělení, Nemocnice Jihlava

The case of a 53 years old patient with a papulopustulous forms of rosacea accompanied with peroral dermatitis is reported. Skinproblems were present for 2 years. In the beginning of problems the patient used local corticoid, later local metronidazol. Beforevisiting aur Acne Clinic she used local corticoid for one month again. All the treatment was without any effect. A therapy withlocal ivermectin cream was started. All regimen recommendations according to a diagnosis of rosacea and perioral dermatitiswere explained. Skin troubles reduced quickly. After healing of all papules an aplication of cream with azelaic acid was started.After 4 months patient´s skin was healed, only slight centrofacial erythema was present. The patient is still in a follow-up of ourAcne clinic. She is applying local cream with azelaic acid and following all recommendations by now.

Keywords: rosacea, papulopustulous form, perioral dermatitis, therapy, regimen recommendations

Published: October 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. The combination of a papulopustulous rosacea with a perioral dermatitis at a 53 years old patient. Dermatol. praxi. 2017;11(3):136-140. doi: 10.36290/der.2017.026.
Download citation

References

  1. Rulcová J. Rosacea faciei - etiologie a patogeneze. Referátový výběr z dermatovenerologie 2013; 55(5): 1-5.
  2. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J EurAcad Dermatol Venereol 2010; 24: 565-571. Go to original source... Go to PubMed...
  3. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46(4): 584-587. Go to original source... Go to PubMed...
  4. Rulcová J. Rosacea faciei - standardní klasifikace. Referátový výběr z dermatovenerologie 2013; 55(5): 6-11.
  5. Dolenc-Voljc M, Pohar M, Lunder T: Density of Demodex folliculorum in perioral dermatitis. Acta Derm Venereol 2005; 85(3): 211 Go to original source... Go to PubMed...
  6. Duchková H. Periorální dermatitida. Referátový výběr z dermatologie 2015; 1(57): 5-10. Go to original source...
  7. Duchková H. Trendy v léčbě periorální dermatitidy. Dermatol pro praxi 2016; 10(1): 16-19. Go to original source...
  8. Korting HC, Schöllmann C. Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 2009; 23: 876-882. Go to original source... Go to PubMed...
  9. Braun-Falco O, Plewig G, Wolf HH, Burgdorf WHC. Dermatology. 2nd edition. Springer, Berlin, Heidelberg, New York, 2000: 1071-1075. Go to original source...
  10. Hall CS, Reichenberg J. Evidence based review of perioral dermatitis therapy. G Ital Dermatol Venereol. 2010 Aug. 145(4): 433-444.
  11. Del Rosso JQ. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. Cutis 2006; 77(2 Suppl): 22-24. Go to PubMed...
  12. Nevoralová Z. Periorální dermatitida. In: Nevoralová Z, Rulcová J, Benáková N. Obličejové dermatózy, Mladá fronta 2016, ISBN 978-80-204-4107-2: 145-151.
  13. Rezakovič S, Mokos ZB, Paštar Z. Pyridoxine induced Rosacea-like dermatitis. Acta Clin Croat 2015; 54: 99-102. Go to PubMed...
  14. Gupta G, Daigle D, Gupta AK, et al. Ivermectin 1% cream for rosacea. Skin Therapy Lett 2015; 20: 9-11. Go to PubMed...
  15. Taieb, A, Ortonne, JP, Ruzicka, T, et al. Ivermectin Phase III Study Group. Superiority of ivermectin 1% cream over metronidazole 0,75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol 2015; 172: 1103-1110. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.